Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioPharma-Reporter" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioPharma-Reporter for you to read. Along with our medical data and news we also list BioPharma-Reporter Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPharma-Reporter Companies for you to search.
Lonza and BioWaâs POTELLIGENT CHOK1SV technology will be licensed by Tillots Pharma to develop its antibody pipeline.
Abzena has gained access to a major mammalian cell line depository it says will cut license negotiations for its customers.
Nohla Therapeutics has selected WuXi AppTec Advanced Therapies to make its lead candidate, indicated to treat patients with hematologic malignances.
Zelluna Immunotherapy has selected MaSTherCell as manufacturing partner for its T-cell receptor (TCR)-based immunotherapies.
The CMO says adding the single-use offering from ABEC will make the newly opened biomanufacturing site in China comparable to stainless steel for commercial mAb production.
The traditionally small molecule firm was âlate to the biologics gameâ, but Sanofi says a mixture of external partnerships and mergers are helping shift focus.
Samsung BioLogics will begin offering its own CHO cell line for its customersâ development projects from 2019.
Mundipharma says it is not concerned at arriving second to market with a trastuzumab biosimilar after inking a deal to commercialise Celltrionâs Herzuma in seven European countries.
LenioBio will offer cell-free protein expression (CFPE) kits for drug screening through a partnership with DowDuPont, and says it is looking into using the tech for bioprocessing.
Both upstream and downstream systems provided by Sartorius Stedim Biotech have been installed in ABLâs facility in Strasbourg, France.
Sharing a facility with a CMO gives Sanofi the flexibility to adjust biomanufacturing capacity according to its needs, says its SVP for biologics.
Pfenex says it is actively looking for partners for its Lucentis and Neulasta biosimilar programmes, which are presently on hold.
BIA Separations has teamed with Nuvonis Technologies to help vaccine and cell therapy developers tackle the transition from upstream to downstream processing.
Egg adaptation is the biggest culprit in this yearâs poor flu vaccine efficacy says Novavax, a firm developing a product based on recombinant protein nanoparticles.
Compugen has selected Selexisâ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.
iBio has expanded its offering to develop and manufacture Fc fusion therapeutics using it plant-based expression system.
Regenxbio says a manufacturing contract with Fujifilm Diosynth Biotechnologies will support its gene therapy candidates.
WuXi BioLogics will develop and manufacture Adageneâs antibody therapeutics for the Chinese market before expanding globally.
Berkeley Lights and MD Anderson Cancer Centre have created a company aimed at developing autologous cell therapies to treat solid tumours.
Merck & Co. will take on Roche as Ontruzant becomes the first biosimilar of cancer drug Herceptin (trastuzumab) to be launched in Europe.
Cryoport will open two global centres and has inked a deal with McKesson to support the growth in demand for cell and gene therapy logistics.
Bioprocessing vendor ABEC has added microbial fermentation capabilities to its single-use line.
Irelandâs National Biosimilar Medicines Policy aims to increase biosimilar use and âdrive downâ the cost of medicines, says government representative.
A gene-inserting technology that effectively implants large molecules into cells could help modify T-cells from a patientâs immune system, says researcher.
Draper has designed a microfluidic transduction device (MTD) it claims will help CAR T-cell therapy developers lower costs, up efficiency â and potentially bring manufacturing to the patientâs bedside.